Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of statement cash flows for partly owned subsidiary (Details)

v3.23.1
SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of statement cash flows for partly owned subsidiary (Details) - CAD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure Of Summarized Financial Information For Partly Owned Subsidiary [Line Items]      
From operating activities $ (12,640) $ (34,372) $ (7,919)
From investing activities (1,408) (9,012) (4,075)
From financing activities 4,762 48,731 6,740
Effect of foreign exchange on cash and cash equivalents (2,168) (329) 213
Net increase in cash and cash equivalents (11,454) 5,018 $ (5,041)
Focus Medical Herbs Ltd [Member]      
Disclosure Of Summarized Financial Information For Partly Owned Subsidiary [Line Items]      
From operating activities (9,635) 2,346  
From investing activities 2,825 (783)  
From financing activities 3,947 560  
Effect of foreign exchange on cash and cash equivalents (110) 169  
Net increase in cash and cash equivalents $ (2,973) $ 2,292